McGuire Investment Group, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
McGuire Investment Group, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,062,000
-29.9%
228,810
-6.9%
0.39%
-30.5%
Q2 2021$2,941,000
-14.0%
245,718
-9.9%
0.56%
-22.6%
Q1 2021$3,418,000
+615.1%
272,801
+789.9%
0.72%
+511.0%
Q4 2020$478,000
+133.2%
30,655
+41.2%
0.12%
+93.4%
Q3 2020$205,000
+0.5%
21,710
-4.8%
0.06%
-14.1%
Q2 2020$204,000
+46.8%
22,800
+4.6%
0.07%
+22.4%
Q1 2020$139,000
-20.1%
21,800
+4.8%
0.06%
+11.5%
Q4 2019$174,000
+58.2%
20,800
+71.9%
0.05%
+44.4%
Q3 2019$110,00012,1000.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders